1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Remicade (infliximab) Drug Market Size Growth Rate by Type (2020-2025)
1.3.2 Brands Drugs
1.3.3 Generic Drugs
1.4 Market Segment by Application
1.4.1 Global Remicade (infliximab) Drug Market Share by Application (2020-2025)
1.4.2 Crohn\'s Disease
1.4.3 Pediatric Crohn\'s Disease
1.4.4 Ulcerative Colitis
1.4.5 Pediatric Ulcerative Colitis
1.4.6 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Remicade (infliximab) Drug Production Value 2015-2025
2.1.2 Global Remicade (infliximab) Drug Production 2015-2025
2.1.3 Global Remicade (infliximab) Drug Capacity 2015-2025
2.1.4 Global Remicade (infliximab) Drug Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2025
2.2.1 Global Remicade (infliximab) Drug Market Size CAGR of Key Regions
2.2.2 Global Remicade (infliximab) Drug Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Remicade (infliximab) Drug Capacity by Manufacturers
3.1.2 Global Remicade (infliximab) Drug Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Remicade (infliximab) Drug Revenue by Manufacturers (2015-2019)
3.2.2 Remicade (infliximab) Drug Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Remicade (infliximab) Drug Market Concentration Ratio (CR5 and HHI)
3.3 Remicade (infliximab) Drug Price by Manufacturers
3.4 Key Manufacturers Remicade (infliximab) Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Remicade (infliximab) Drug Market
3.6 Key Manufacturers Remicade (infliximab) Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Brands Drugs Production and Production Value (2015-2019)
4.1.2 Generic Drugs Production and Production Value (2015-2019)
4.2 Global Remicade (infliximab) Drug Production Market Share by Type
4.3 Global Remicade (infliximab) Drug Production Value Market Share by Type
4.4 Remicade (infliximab) Drug Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Remicade (infliximab) Drug Consumption by Application
6 Production by Regions
6.1 Global Remicade (infliximab) Drug Production (History Data) by Regions 2015-2019
6.2 Global Remicade (infliximab) Drug Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Remicade (infliximab) Drug Production Growth Rate 2015-2019
6.3.2 United States Remicade (infliximab) Drug Production Value Growth Rate 2015-2019
6.3.3 Key Players in United States
6.3.4 United States Remicade (infliximab) Drug Import & Export
6.4 European Union
6.4.1 European Union Remicade (infliximab) Drug Production Growth Rate 2015-2019
6.4.2 European Union Remicade (infliximab) Drug Production Value Growth Rate 2015-2019
6.4.3 Key Players in European Union
6.4.4 European Union Remicade (infliximab) Drug Import & Export
6.5 China
6.5.1 China Remicade (infliximab) Drug Production Growth Rate 2015-2019
6.5.2 China Remicade (infliximab) Drug Production Value Growth Rate 2015-2019
6.5.3 Key Players in China
6.5.4 China Remicade (infliximab) Drug Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Remicade (infliximab) Drug Consumption by Regions
7.1 Global Remicade (infliximab) Drug Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Remicade (infliximab) Drug Consumption by Type
7.2.2 United States Remicade (infliximab) Drug Consumption by Application
7.3 European Union
7.3.1 European Union Remicade (infliximab) Drug Consumption by Type
7.3.2 European Union Remicade (infliximab) Drug Consumption by Application
7.4 China
7.4.1 China Remicade (infliximab) Drug Consumption by Type
7.4.2 China Remicade (infliximab) Drug Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Remicade (infliximab) Drug Consumption by Type
7.5.2 Rest of World Remicade (infliximab) Drug Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Janssen
8.1.1 Janssen Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Remicade (infliximab) Drug
8.1.4 Remicade (infliximab) Drug Product Introduction
8.1.5 Janssen Recent Development
8.2 Hospira
8.2.1 Hospira Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Remicade (infliximab) Drug
8.2.4 Remicade (infliximab) Drug Product Introduction
8.2.5 Hospira Recent Development
8.3 Celltrion Healthcare
8.3.1 Celltrion Healthcare Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Remicade (infliximab) Drug
8.3.4 Remicade (infliximab) Drug Product Introduction
8.3.5 Celltrion Healthcare Recent Development
8.4 Epirus Biopharmaceuticals
8.4.1 Epirus Biopharmaceuticals Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Remicade (infliximab) Drug
8.4.4 Remicade (infliximab) Drug Product Introduction
8.4.5 Epirus Biopharmaceuticals Recent Development
8.5 Samsung Bioepsis
8.5.1 Samsung Bioepsis Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Remicade (infliximab) Drug
8.5.4 Remicade (infliximab) Drug Product Introduction
8.5.5 Samsung Bioepsis Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Remicade (infliximab) Drug Capacity, Production Forecast 2020-2025
9.1.2 Global Remicade (infliximab) Drug Production Value Forecast 2020-2025
9.2 Market Forecast by Regions
9.2.1 Global Remicade (infliximab) Drug Production and Value Forecast by Regions 2020-2025
9.2.2 Global Remicade (infliximab) Drug Consumption Forecast by Regions 2020-2025
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Remicade (infliximab) Drug Production Forecast by Type
9.7.2 Global Remicade (infliximab) Drug Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Remicade (infliximab) Drug Sales Channels
10.2.2 Remicade (infliximab) Drug Distributors
10.3 Remicade (infliximab) Drug Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porter\'s Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
